Cardiac resynchronization therapy: Clinical results and evolution of candidate selection

European Heart Journal, Supplement

Volumn 9, Issue I, 2007, Pages

  Leclercq, Christophe ^a   Bleeker, Gabe B ^b   Linde, Cecilia ^c   Donal, Erwan ^a   Bax, Jeroen J ^b   Schalij, Martin J ^b   Daubert, Claude ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biventricular pacing; Cardiac resynchronization therapy; Cardiomyopathy; Echocardiography; Heart failure; Remodelling

Indexed keywords

EID: 77149172672     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sum066     Document Type: Article

References (53)

1. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344: 873-880.
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. For the MIRACLE Study Group. N Engl J Med 2002;346:1845-1853.
3. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-1787.
4. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-1459.
5. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-2694.
6. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
7. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
8. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001;7:176-182.
9. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27:1928-1932.
10. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000;35:569-582.
11. Bristow MR, Gilbert EM, Abraham WT et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996;94:2807-2816.
12. Kawai K, Takaoka H, Hata K et al. Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy. Am J Cardiol 1999;84:671- 676.
13. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033.
14. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-118.
15. Abraham WT, Young JB, Leon AR et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverterdefibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-2868.
16. Linde C, Gold MR, Abraham WT, Daubert JC. Rationale and design of a randomised controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure-the REsynchronization reVErses Remodeling in Systolic Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J 2006;151:288-294.
17. Moss A, Borwn MW, Cannom DS, Daubert JP, Estes M, Foster E, Greenberg HM, Hall WJ, Klein H, Pfeffer M, Wilber D, Zareba W. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol 2005;10:34-43.
18. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 2006;27:2682-2688.
19. Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JG. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction-a systematic review and meta-analysis. Eur J Heart Fail 2006;8:433-440.
20. Abdulla J, Haarbo J, Kober L, Torp-Pedersen C. Impact of implantable defibrillators and resynchronization therapy on outcome in patients with left ventricular dysfunction-a meta-analysis. Cardiology 2006;106:249- 255.
21. McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004;141:381-390.
22. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289:730-740.
23. Swedberg K, Cleland J, Dargie H et al. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140.
24. Hunt S, Abraham W, Chin M et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. J Am Coll Cardiol 2005;46:1116-1143.
25. Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O, Mugica J. Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol 1996;19:1748-1757.
26. Bakker PF, Meijburg H, de Vries JW et al. Biventricular pacing in endstage heart failure improves functional capacity and left ventricular function. J Interv Card Electrophysiol 2000;4:395-404.
27. Liedenfeld JA, Feldman AM, Saxon L et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 2007;115:204-212.
28. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002;39:194-201.
29. Grines CL, Bashore TM, Boudoulas H et al. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation 1989;79:845-853.
30. Bader H, Garrigue S, Lafitte S et al. Intra-left ventricular electromechanical asynchrony: a new independent predictoe of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004;43:248- 256.
31. Yu CM, Lin H, Zhang Q et al. High prevalence of systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54-60.
32. Bleeker G, Schalij M, Molhoek S et al. Relationship between QRS duration and left ventricular dyssynchrony patients with end-stage heart failure. J Cardiovasc electrophysiol 2004;15:544-549.
33. Hawkins N, Petrie M, MacDonald M et al. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? Eur Heart J 2006;27:1270-1281.
34. Bax JJ, Bleeker GB, Marwick TH et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834-1840.
35. Yu CM, Chau E, Sanderson JE et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002;105:438-445.
36. Bordachar P, Lafitte S, Reuter S et al. Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing. J Am Coll Cardiol 2004;44:2154-2165.
37. Pitzalis MV, Iacoviello M, Romito R et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-1622.
38. Pitzalis MV, Iacoviello M, Romito R et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol 2005;45:65- 69.
39. Marcus GM, Rose E, Viloria EM et al. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 2005;46:2208-2214.
40. Yu CM, Zhang Q, Wing-Hong Fung J et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol 2005;45:677-684.
41. Yu CM, Fung JW, Zhang Q et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 2004;110:66-73.
42. Breithardt OA, Stellbrink C, Herbots L et al. Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block. J Am Coll Cardiol 2003;42:486-494.
43. Dohi K, Suffoletto MS, Schwartzman D et al. Utility of Echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchronization therapy. Am J Cardiol 2005;96:112-116.
44. Suffoletto MS, Dohi K, Cannesson M et al. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 2006;113:960-968.
45. Kapetenakis S, Kearney MT, Siva A et al. Real-time three-dimensional echocardiography. Circulation 2005;112:992-1000.
46. Yu CM, Abraham W, Bax J et al. Predictors of response to cardiac resynchronization therapy (PROSPECT) - study design. Am Heart J 2005;149:600-605.
47. Yao G, Freemantle N, Calvert M et al. The long term costeffectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007;28:42-51.
48. Gasparini M, Auricchio A, Regoli F et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression. J Am Coll Cardiol 2006;48:734-743.
49. Abraham WT, Young JB, Leon AR et al. Effects of cardiac resynchronization therapy on disease progression in patients with left ventricular systolic dysfunction, a, indication for an implantable cardioverter defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-2868.
50. Yu CM, Chan YS, Zhang Q et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006;48:2251-2257.
51. Bleeker G, Holman E, Steendjik P et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006;48:2243-2250.
52. Manolis A. The deleterious consequences of right ventricular apical pacing: time to seek alternate site pacing. Pacing Clin Electrophysiol 2006;29:298-315.
53. Kindermann M, Hennen B, Jung J et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927-1937.